Allergy Diagnostics Global Market Report 2022: Rising Air Pollution Fuels Rapid Sector Expansion - ResearchAndMarkets.com

The "Allergy Diagnostics Market By Test Type, By Product & Service, By Allergen, By End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

According to the report, 'Allergy Diagnostics Market,' the allergy diagnostics market size was valued at $5 billion in 2021, and is estimated to reach $16.7 billion by 2031, growing at a CAGR of 13.2% from 2022 to 2031.

The global market for allergy diagnostics is expanding dramatically, mostly as a result of rising air pollution that can lead to chronic respiratory illnesses. Additionally, according to the WHO (World Health Organization), 80% of people live in metropolitan areas, making them particularly vulnerable to the effects of poor air quality, especially in low-income nations.

In addition, several studies have shown a connection between air pollution and allergic rhinitis, asthma, and other conditions, which is fueling the expansion of the allergy diagnostics market growth. Likewise, businesses that are just starting in the allergy diagnostic sector are already setting the pace for other market competitors in terms of developing new customer-focused strategies.

For instance, the National Measurement Laboratory (NML) of the UK, introduced the first-ever multi-allergen reference material kit including five common allergens at LGC on February 20, 2020. Egg, milk, walnut, hazelnut, and almond are a few of the typical allergens included in kits. It is also anticipated that market expansion would be fueled by these kinds of activities by industry players.

Due to the high cost of allergy testing equipment, the cost of service is considerable. ELISA analyzers, luminometers, immunoassay analyzers, blot analyzers, and scanners are a few examples of frequently used diagnostic tools. Additionally, the price of an immunoassay analyzer is $10,000, while fully automated analyzers cost around $14,000 each. Such equipment also needs upkeep, lab supervision, operational costs, and other things. In the upcoming years, all of these factors are projected to reduce the market value of allergy diagnostics.

Due to the rapid expansion of the global allergy diagnostics industry, researchers and scientists have accelerated their R&D efforts to create cutting-edge technological gadgets for better allergy diagnostic usage on mobile phones. Additionally, using motion sensors, messaging, cameras, and video calls can aid allergists in communicating with their patients, thanks to the integration of mHealth in allergy diagnostics.

As a result, allergy diagnostic via mobile health tools aids clinicians in determining the severity of allergies through the documenting of symptoms, favorably influencing the market expansion. Leading companies in the allergy diagnostic sector are already using innovative customer-drawing tactics.

Key Market Segments

By Test Type

• In Vitro
• In Vivo

By Product Service

• Consumables
• Instruments
• Services

By Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

By End-user

• Diagnostic Laboratories
• Hospital-based Laboratories
• Academic Research Institutes
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• United Arab Emirates
• South Africa
• Rest of LAMEA

Key Market Players

• Alerchek Inc.
• Danaher Corp
• Hitachi chemical Diagnostic Inc.
• HOB Biotech Group Co. Ltd.
• Hycor Biomedical Inc.
• Lincoln Diagnostics Inc.
• Omega Diagnostic Llc
• Siemens Healthcare Diagnostics, Inc.
• Stallergenes SA
• Thermo Fisher Scientific Inc.
• Thermo Fisher Scientific Inc.
• Danaher
• Omega Diagnostics Group PLC
• Eurofins Scientific
• bioMerieux SA
• HollisterStier Allergy
• Minaris Medical America, Inc.
• ACON Laboratories, Inc.
• Lincoln Diagnostics, Inc.
• Neogen Corporation

Key Findings of the Study

• Based on test type, the in vivo sub-segment emerged as the global leader in 2021, and In vitro sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.
• Based on product/service, the consumable sub-segment emerged as the global leader in 2021, as well as it is anticipated to be the fastest growing sub-segment during the forecast period.
• Based on allergen, the inhaled allergens sub-segment emerged as the global leader in 2021 and the food allergens sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.
• Based on end-user, the diagnostic laboratories sub-segment emerged as the global leader in 2021, as well as it is predicted to show the fastest growth in the upcoming years.
• Based on region, the North America market registered the highest market share in 2021 and the Asia-Pacific market is predicted to show the fastest growth in the upcoming years.
• The study provides in-depth analysis of the Allergy Diagnostics Market share across the various regions.

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE

CHAPTER 5: WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE

CHAPTER 6: WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN

CHAPTER 7: WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER

CHAPTER 8: WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

For more information about this report visit https://www.researchandmarkets.com/r/9vgr9c

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230112005589/en/